TOL101

· Tolera Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TOL101, covering 2013-06-11 to 2013-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection [Phase 1, Phase 2]

See pricing